Time Medical International Ventures (India) Pvt Ltd, a wholly owned subsidiary of the Company announces New Low-Field TOF MRI Platform for Nationwide Aneurysm Screening, Developed in Collaboration with Dr. Iype Cherian
Fischer Medical Ventures Ltd Press Release Nov 17 2025
Filed with NSE · · 5 pages · English
Summary by 6ix AI
The new MRI platform, named VEGA, aims to enhance accessibility to neurovascular screening across India, targeting a significant population at risk for unruptured intracranial aneurysms. The press release highlights the importance of early detection and the innovative design of the VEGA system, which is cost-effective and suitable for deployment in various healthcare settings.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Fischer Medical Ventures Ltd on 6ix
Earlier from Fischer Medical Ventures
- Press Release Nov 13 2025
- Press Release (Revised) Nov 11 2025
- Press Release Nov 11 2025
- Press Release Nov 04 2025
- Press Release Nov 03 2025
Later from Fischer Medical Ventures
- Fischer Medical Ventures Ltd Press Release Dec 01 2025
- Press Release Feb 09 2026
- Press Release May 14 2026
- Fischer Medical Ventures Ltd Press Release Jul 30 2026
- Fischer Medical Ventures Ltd Press Release Jul 31 2026
Follow Fischer Medical Ventures into a list and get an email when it puts out news.
Follow Fischer Medical Ventures